The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy

Description

This protocol pertains specifically to the prospective lung squamous cell carcinoma pre-malignant lesion (PML) cohort that will form a primary study group for the Lung Pre-Cancer Atlas.

Conditions

Lung Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This protocol pertains specifically to the prospective lung squamous cell carcinoma pre-malignant lesion (PML) cohort that will form a primary study group for the Lung Pre-Cancer Atlas.

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy

Condition
Lung Cancer
Intervention / Treatment

-

Contacts and Locations

Aurora

Rocky Mountain Regional VAMC, Aurora, Colorado, United States, 80045

Aurora

UCHealth - Metro, Aurora, Colorado, United States, 80045

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. A current or ex-smoker with a \> 20 pack-year history of smoking.
  • 2. History of non-small cell lung cancer (stage I, II, or IIIA) with\> 10 pack-year history of smoking and no evidence of active disease at least 1 year after definitive treatment.
  • 3. History of head and neck cancer (stage I, II, III, or IVA) with \> 10 pack-year history of smoking and no evidence of active disease at least 1 year after definitive treatment.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Colorado, Denver,

Robert Keith, MD, PRINCIPAL_INVESTIGATOR, University of Colorado, Denver

Study Record Dates

2026-01